Cytek Biosciences (CTKB) Net Margin (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Net Margin came in at 42.75% in Q1 2026, down 1524.0% YoY from 3.0% in Q1 2025, and up 39.73% on a QoQ basis from 70.93% in Q4 2025.
Cytek Biosciences (CTKB) Net Margin (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Net Margin data on file, last reported at 42.75% in Q1 2026.
- Quarterly Net Margin fell 1524.0% year-over-year to 42.75% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 36.25% (down 3054.0% YoY) and the FY2025 annual result came in at 33.02%, down 3002.0% from the prior year.
- Net Margin grew to 42.75% in Q1 2026, from 70.93% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 16.78% in Q4 2024 to a low of 70.93% in Q4 2025.
- A 5-year average of 12.26% and a median of 10.48% in 2025 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2024 — Net Margin jumped 1528 bps — and 2025, when it sank 8771 bps.
- Tracing CTKB's Net Margin over 5 years: stood at 7.3% in 2022, then gained by 29 bps to 9.45% in 2023, then surged by 78 bps to 16.78% in 2024, then sank by 523 bps to 70.93% in 2025, then jumped by 40 bps to 42.75% in 2026.
- The last three Net Margin figures came in at 42.75% (Q1 2026), 70.93% (Q4 2025), and 10.48% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.37% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 19.37% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 16.67% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 19.04% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.84% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 6.47% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 13.47% |
| 10 | Cytek Biosciences | 602.64 Mn | 528.79 Mn | 28.34 Mn | -25.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.26% |
| Mar 31, 2026 | -42.75% |
| Dec 31, 2025 | -70.93% |
| Sep 30, 2025 | -10.48% |
| Jun 30, 2025 | -12.24% |
| Mar 31, 2025 | -27.50% |
| Dec 31, 2024 | 16.78% |
| Sep 30, 2024 | 1.83% |
| Jun 30, 2024 | -22.38% |
| Mar 31, 2024 | -13.75% |
| Dec 31, 2023 | 9.45% |
| Sep 30, 2023 | -13.45% |
| Jun 30, 2023 | -8.83% |
| Mar 31, 2023 | -18.35% |
| Dec 31, 2022 | 7.30% |
| Sep 30, 2022 | 4.12% |
| Jun 30, 2022 | -1.49% |
| Mar 31, 2022 | -5.76% |
| Sep 30, 2021 | 1.01% |
| Mar 31, 2021 | 0.42% |